• Bladder Cancer 821 global 1 1.25 9 1.25 1.25 Roundtable 0 1
  Enhancing the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer With Immunotherapy-Based Regimens
  Urology2023-05-22 20:00:00
  Did you know that immunotherapy-based regimens are being used to treat patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC) leading to improved outcomes?
  
  1.25ABIM MOC 1.25CME/CE 75MIN

  
  Save
• Non-Small Cell Lung Cancer 3004986 us 1 0.5 9 0.5 0.5 Roundtable 0 1
  Early-Stage Resectable Non-Small Cell Lung Cancer: Sharing Patient Perspectives
  General Surgery2023-05-03 20:00:00
  The complexity of treatment has increased dramatically; how effectively are you communicating with your patients?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Melanoma 65 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm
  Hematology-Oncology2023-04-20 20:00:00
  Are you up to date on the use of lymphocyte-activation gene 3 (LAG3) inhibitors to treat patients with metastatic melanoma?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Acute Pain 5000003 global 1 0.5 9 0.5 2 0.5 0.5 Roundtable 0 1
  Hot Topics in Anesthesia: A Review of Recent Guidelines for the Reversal of Neuromuscular Blockade (NMB) 
  Anesthesiology2023-04-13 20:00:00
  Have you heard about the new practice guidelines on monitoring and antagonism of NMB?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Breast Cancer 840 global 1 0.75 9 0.75 2 0.75 0.75 Roundtable 0 1
  Conceptualizing Guidelines to Manage Patients With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
  Hematology-Oncology2023-03-28 20:00:00
  What do the guidelines say about treating patients with early breast cancer at high risk for recurrence?
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Breast Cancer 840 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines
  Hematology-Oncology2023-03-26 20:00:00
  Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Diverticular Disease 3003530 global 1 0.25 9 0.25 2 0.25 8 0.25 0.25 Clinical Brief 0 1
  Does Surgery Improve Quality of Life for Patients With Recurrent Diverticulitis?
  Gastroenterology2023-06-01 20:00:00
  Elective sigmoid resection for recurrent or painful diverticulitis should be considered, using shared decision-making with the patient.
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Bladder Cancer 821 global 1 1.25 9 1.25 1.25 Roundtable 0 1
  Enhancing the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer With Immunotherapy-Based Regimens
  Urology2023-05-22 20:00:00
  Did you know that immunotherapy-based regimens are being used to treat patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC) leading to improved outcomes?
  
  1.25ABIM MOC 1.25CME/CE 75MIN

  
  Save
• Skin and Soft Tissue Infection 3029299 global 1 1.0 9 1.0 1.0 Journal Article 0 1
  Three Unusual Cases of Francisella tularensis-Related Prosthetic Joint Infection in France, and a Literature Review of 5 Cases
  Infectious Diseases2023-05-17 20:00:00
  A case series of Francisella tularensis-related prosthetic joint infection supports surgical treatment with long-term antibiotics.
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Non-Small Cell Lung Cancer 3004986 us 1 0.5 9 0.5 0.5 Roundtable 0 1
  Early-Stage Resectable Non-Small Cell Lung Cancer: Sharing Patient Perspectives
  General Surgery2023-05-03 20:00:00
  The complexity of treatment has increased dramatically; how effectively are you communicating with your patients?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Acute Pain 5000003 global 1 0.5 9 0.5 0.5 Clinical Brief 0 1
  Show Codes, Slow Codes, Full Codes, or No Codes: What Is a Doctor to Do?
  Internal Medicine2023-04-24 20:00:00
  A show code, even with patient/family consent, undermines patient autonomy, patient-physician relationships, and professional integrity.
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Melanoma 65 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm
  Hematology-Oncology2023-04-20 20:00:00
  Are you up to date on the use of lymphocyte-activation gene 3 (LAG3) inhibitors to treat patients with metastatic melanoma?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Acute Pain 5000003 global 1 0.5 9 0.5 2 0.5 0.5 Roundtable 0 1
  Hot Topics in Anesthesia: A Review of Recent Guidelines for the Reversal of Neuromuscular Blockade (NMB) 
  Anesthesiology2023-04-13 20:00:00
  Have you heard about the new practice guidelines on monitoring and antagonism of NMB?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Breast Cancer 840 global 1 0.75 9 0.75 2 0.75 0.75 Roundtable 0 1
  Conceptualizing Guidelines to Manage Patients With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
  Hematology-Oncology2023-03-28 20:00:00
  What do the guidelines say about treating patients with early breast cancer at high risk for recurrence?
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Breast Cancer 840 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines
  Hematology-Oncology2023-03-26 20:00:00
  Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Inflammatory Bowel Disease 3032545 global 1 1.0 1.0 Clinical Review 0 1
  Northwestern Medicine Presents: The Future of Inflammatory Bowel Disease Management
  Gastroenterology2023-03-22 20:00:00
  Dr. Parambir Dulai discusses new therapies and treatments for IBD, as well as what is on the horizon for IBD patients.
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Breast Cancer 840 global 1 1.0 9 1.0 1.0 Clinical Case 0 1
  Adjuvant Therapy in Hormone Receptor Positive/HER2-Negative Early Breast Cancer: Case Simulations
  Hematology-Oncology2023-03-20 20:00:00
  Do you know the best approaches for identifying and managing high-risk, hormone receptor positive early breast cancer?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• 0 global 1 1.0 1.0 Clinical Case 0 1
  A Patient Simulation: Can You Diagnose These Patients With Painful Abscesses and Skin Nodules?
  Dermatology2023-03-09 19:00:00
  What would you do if your patient had painful abscesses and skin nodules?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Head and Neck Cancer 3004984 global 1 1.0 9 1.0 2 1.0 1.0 Clinical Review 0 1
  Neuro-Oncology Updates: Insights on the Diagnosis and Management of Low-Grade Glioma, Glioblastoma, and NF1
  Hematology-Oncology2023-03-09 19:00:00
  Did you know that targeted agents and immunotherapies are improving outcomes in patients with low-grade and high-grade brain tumors?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Melanoma 65 global 1 0.25 9 0.25 0.25 Commentary 0 1
  Depicting LAG3: Exploring a New Target in Metastatic Melanoma
  Hematology-Oncology2023-03-08 19:00:00
  Do you know the role of lymphocytic activation gene 3 (LAG3) in metastatic melanoma and its potential as a treatment target?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Lung Cancer 5000186 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Community Considerations: Expanding the Utility of Immunotherapy in Patients With Non–Small Cell Lung Cancer
  Hematology-Oncology2023-02-27 19:00:00
  Do you know the latest information on immunotherapy for the management of non-small cell lung cancer (NSCLC)?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Aesthetic Medicine 5000574 global 1 0.5 2 0.5 0.5 Roundtable 0 1
  The Complete Guide to Chemical Peels: Why, What, and How?
  General Surgery2023-02-26 19:00:00
  Chemical peeling can yield great results in skin rejuvenation; our experts explain what you need to know to start peeling in your own practice.
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Biologic Therapy 5000033 global 1 0.25 9 0.25 0.25 Clinical Review 0 1
  What's Your Take? Perspectives on Immunotherapy for Early-Stage Solid Tumors
  Hematology-Oncology2023-02-22 19:00:00
  Did you know? Immunotherapy is now being used for the neoadjuvant and adjuvant treatment of solid tumors -- find out more here!
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Glioblastoma 1541 global 1 0.25 9 0.25 0.25 Clinical Review 0 1
  Case in Point: An Expert's Approach to Caring for Patients With Glioblastoma
  Hematology-Oncology2023-02-21 19:00:00
  A 65-year-old patient, John, presents with rapid, progressive left-sided weakness. You suspect glioblastoma. What would you do next?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save

Education For Your Patient

• Click here for access to online educational resources to share with your patients and their care partners

Policies and Requirements

• CME Policies
• State CME Requirements